Physician profile
John C Rogers
NPI 1194828020
$2,266.24
in general payments reported to CMS, 2019-2025
22 companies · $13.77 in 2025
The $13.77 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.24 · 2020: $88.27 · 2021: $1,074 · 2022: $561 · 2023: $358 · 2024: $158 · 2025: $13.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $530.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $466.36 | 2021-2022 | |
| Amgen INC. | $420.63 | 2021-2024 | Evenity, Otezla |
| Abbvie INC. | $329.18 | 2021-2025 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $220.06 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $158.79 | 2022-2023 | Quviviq |
| Inspire Medical Systems, INC. | $124.74 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $75.15 | 2019-2022 | |
| Daiichi Sankyo INC. | $60.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.94 | 2021 | |
| Eisai INC. | $52.84 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $51.87 | 2020 | |
| Lilly USA, LLC | $45.29 | 2021 | |
| Glaxosmithkline, LLC. | $30.70 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $28.72 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.97 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $20.47 | 2022 | |
| Allergan, INC. | $20.03 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $18.92 | 2021 | |
| Pfizer INC. | $15.30 | 2022 | |
| Horizon Therapeutics Plc | $14.42 | 2021 | |
| Abbott Laboratories | $14.35 | 2021 | |
| Genentech USA, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.